Abstract:Hydrogen sulfide (H2S) is a specific substance in the tumor microenvironment, and highly expressed H2S can be used to activate some agents for intelligent treatment of tumors. However, not all tumors contain overexpressed hydrogen sulfide. To address this obstacle, we report the design of theranostic nanoplatforms with glutathione-triggered H2S generation and H2S-triggered therapy activation functions, by using hollow mesoporous organosilica nanoparticles (HMON) to load Cu-HMME framework nanodots (CuHF) and garlic extract diallyl trisulfide (DATS). Such CuHF/DATS@HMON with sizes of about 110 nm exhibit obvious quenching fluorescence and is inactive. Importantly, when CuHF/DATS@HMON is mixed with glutathione (GSH) solution, the nucleophilic attack of GSH on trisulfide bonds (−S-S-S-) in DATS generates S-allyl glutathione disulfide (GSSA) and allyl perthiol (ASSH), with the latter releasing H2S upon reduction by GSH, conferring the overexpress of H2S as the first-cascade activation. Furthermore, endogenous H2S can react with CuHF to produce CuS nanoparticles with strong chemodynamic/photothermal effect and to release metal porphyrin ((Cu)HMME) with photodynamic effect, as the second-cascade activation. When CuHF/DATS@HMON is accumulated at the tumor site through EPR effect, DATS in the CuHF/DATS@HMON can react with endogenous glutathione (GSH) in cancer cells to in situ generate H2S, and then H2S can vulcanize CuHF to generate CuS nanoparticles and (Cu)HMME complexes, thus realizing chemokinetic, photodynamic and photothermal multi-mode therapy to inhibit tumor growth. At the same time, the tetrasulfide bonds (−S-S-S-S-) in HMON allow the material to be slowly broken down and metabolized. Therefore, this study not only provides a general design for constructing tumor-microenvironment-responsive agents, but also provides some insights for multi-modal therapy of cancers.

Biodegradable calcium sulfide-based nanomodulators for H 2 S-boosted Ca 2+ -involved synergistic cascade cancer therapy

Biodegradable calcium sulfide-based nanomodulators for H<sub>2</sub>S-boosted Ca<SUP>2+</SUP>-involved synergistic cascade cancer therapy

Nanotherapeutics for Hydrogen Sulfide-Involved Treatment: an Emerging Approach for Cancer Therapy

A biodegradable calcium sulfite nanoreactor for pH triggered gas therapy in combination with chemotherapy

Design of Multifunctional Theranostic Nanoplatforms with Glutathione-Triggered H2S 2 S Generation and H2S-activitated 2 S-activitated Multi-Modal Therapy

Design of Multifunctional Theranostic Nanoplatforms with Glutathione-Triggered H2S Generation and H2S-activitated Multi-Modal Therapy

GSH-Triggered/Photothermal-Enhanced H2S Signaling Molecule Release for Gas Therapy

A Tumor‐Microenvironment‐Responsive Nanocomposite for Hydrogen Sulfide Gas and Trimodal‐Enhanced Enzyme Dynamic Therapy

ZnS@ZIF-8 Core-Shell Nanoparticles Incorporated with ICG and TPZ to Enable H2S-amplified Synergistic Therapy.

H<sub>2</sub>S-Responsive Small-Molecule Nanocarriers for Drug Delivery to Colorectal Tumors

Calcium ion rapid release and dual-mode synergistic regulation influx for enhanced therapeutic efficacy

Nano-modulators with the function of disrupting mitochondrial Ca2+ homeostasis and photothermal conversion for synergistic breast cancer therapy

Self-immolative poly(thiocarbamate) with localized H2S signal amplification for precise cancer imaging and therapy

Mesoporous Organosilica-Based Hydrogen Sulfide Nanogenerator for Enhanced Tumor Chemotherapy

Hydrogen Sulfide Delivery System Based on Salting-Out Effect for Enhancing Synergistic Photothermal and Photodynamic Cancer Therapies

CaCO3-encircled Hollow CuS Nanovehicles to Suppress Cervical Cancer Through Enhanced Calcium Overload-Triggered Mitochondria Damage

Tumor pH-responsive metastable-phase manganese sulfide nanotheranostics for traceable hydrogen sulfide gas therapy primed chemodynamic therapy

Tumor-Selective Biodegradation-Regulated Photothermal H2 S Donor for Redox Dyshomeostasis- and Glycolysis Disorder-Enhanced Theranostics.

Depletion and Downregulation of Hydrogen Sulfide Using an Activatable Probe for Promoting Photothermal Therapy toward Colorectal Cancers

H2S and NIR Light-Driven Nanomotors Induce Disulfidptosis for Targeted Anticancer Therapy by Enhancing Disruption of Tumor Metabolic Symbiosis

Degradable Tumor-Specific H2S Nanogenerators for Disrupting Tumor Metabolic Symbiosis and Activating Anti-Tumor Immune Responses